Related Experiment Video
Updated: May 21, 2025
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Plasma proteomics in pediatric patients with sepsis- hopes and challenges
Shiyuan Fan1,2, Saizhen Zeng3
1Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (Affiliated Hospital of Hunan Academy of Chinese Medicine), Changsha, 410006, China.
Insights
Sepsis is a major cause of death in young children. Plasma proteomics can identify biomarkers to improve diagnosis and risk stratification for pediatric sepsis, potentially saving lives.
Area of Science:
- Pediatric critical care
- Biomarker discovery
- Proteomics
Background:
- Sepsis is a leading cause of mortality and morbidity in children globally.
- Diagnosing sepsis in pediatric patients presents unique challenges compared to adults.
- Early identification and treatment are crucial to prevent organ dysfunction and improve outcomes.
Purpose of the Study:
- To explore the utility of plasma proteomics in identifying sepsis biomarkers in children.
- To investigate the potential of omics technologies for early sepsis diagnosis and prognosis.
- To enhance risk stratification for pediatric sepsis patients.
Main Methods:
- Utilizing plasma proteomics to analyze protein expression profiles in pediatric sepsis.
- Applying omics technologies for biomarker discovery with high diagnostic sensitivity and specificity.
- Developing risk stratification models based on identified proteomic biomarkers.
Main Results:
- Proteomics enables the identification of potential protein biomarkers for sepsis.
- Biomarkers can indicate disease progression and patient response to treatment.
- Risk stratification using proteomic data can improve patient prognosis and identify those at high risk.
Conclusions:
- Plasma proteomics is a promising approach for identifying sepsis biomarkers in pediatric patients.
- Biomarker discovery through proteomics can aid in early diagnosis and personalized treatment strategies.
- This technology can significantly improve the management and outcomes of pediatric sepsis.
Abstract:
One of the main causes of morbidity and death in pediatric patients is sepsis. Of the 48.9 million cases of sepsis reported globally, 41.5% involve children under the age of five, with 2.9 million deaths associated with the disease. Clinicians must identify and treat patients at risk of sepsis or septic shock before late-stage organ dysfunction occurs since diagnosing sepsis in young patients is more difficult than in adult patients. As of right now, omics technologies that possess adequate diagnostic sensitivity and specificity can assist in locating biomarkers that indicate how the disease will progress clinically and how the patient will react to treatment. By identifying patients who are at a higher risk of dying or experiencing persistent organ dysfunction, risk stratification based on biomarkers generated from proteomics can enhance prognosis. A potentially helpful method for determining the proteins that serve as biomarkers for sepsis and formulating theories on the pathophysiological mechanisms behind complex sepsis symptoms is plasma proteomics.
More Related Videos
10:05Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
